Eisai and Biogen Announce Positive Topline Results of the Final Analysis for BAN2401 at 18 Months Read more
Sorrento Acquires the Sofusa Lymphatic Delivery Platform for Immune-Oncology (I-O) Antibody Therapeutics Read more
Juniper Pharma Signs Definitive Agreement to be Acquired by Catalent for $11.50 Per Share in Cash Read more
Pivotal and APRO partner to develop 3 investigator Sponsored Trials in Genitourinary Tumors Read more
Forendo Pharma Initiates Phase I Study for Potential New, Targeted Treatment for Endometriosis Read more
Theratechnologies Submits Novel Single-Vial Formulation of EGRIFTA (Tesamorelin for Injection) for FDA Approval Read more